Tier A

Folate · Vitamin B9 (Folic Acid · 5-MTHF)

Also known as: Folic acid · 5-methyltetrahydrofolate · 5-MTHF · Vitamin B9 · L-methylfolate calcium

2 PMID anchor · BLOOD · REPRODUCTIVE · CARDIO · Last reviewed 2026-06-04

Mechanism of action

  • One-carbon metabolism cofactor (DNA synthesis, methylation, amino acid metabolism)
  • Co-cofactor with B12 in methionine synthase reaction
  • Required for neural tube closure in early embryogenesis (closure window day 21-28 post-conception)

Molecular + tissue targets

  • Erythropoiesis
  • Homocysteine metabolism
  • Embryonic neural tube closure
  • DNA synthesis in dividing cells

Dosage range

400 μg/day periconceptional for first-occurrence NTD prevention (Czeizel 1992 PMID 1307234 NEJM RCT n = 4,156 multivitamin + 0.8 mg folic acid vs trace-element · 0 NTD vs 6 NTD); 4 mg/day for recurrence prevention in women with a prior NTD pregnancy (MRC Vitamin Study 1991 PMID 1677062 Lancet n = 1,195 completed pregnancies · 72% protective effect, RR 0.28, 95% CI 0.12-0.71); RDA 400 μg DFE for adults

Safety notes

Folate supplementation can mask the haematological signs of B12 deficiency while neuropathy progresses — measure or supplement B12 alongside folate in adults > 50 or with malabsorption risk; upper limit 1000 μg/day folic acid from fortified food + supplement (excluding food folate)

Cross-market regulatory status

🇺🇸 FDA

GRAS · DSHEA dietary supplement · 21 CFR 101.79 authorized health claim: folate + neural tube defect risk reduction (food + supplement label); 21 CFR 184.1492 folic acid food additive

🇪🇺 EFSA

Authorized claims Reg 432/2012 (blood formation, homocysteine, maternal tissue growth, etc.) + Commission Reg 1135/2014 implementing Reg 1924/2006 Article 14(1)(a) reduction of disease risk claim for periconceptional 400 µg folic acid lowering NTD risk; NRV 200 μg

🇧🇷 ANVISA

RDC 243/2018 dietary supplement · IN 28/2018 Anexo V alegação funcional verbatim: "O ácido fólico auxilia na formação das células vermelhas do sangue." + additional homocysteine / cell division claims available when nutrient threshold met

Authorized claims · verbatim (5)

Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.

🇪🇺 EFSA · 4 claims

Reg 432/2012

Folate contributes to normal blood formation.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of folate"

Authorized 2012

Reg 432/2012

Folate contributes to maternal tissue growth during pregnancy.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of folate" + the claim must be accompanied by information that a balanced and varied diet plus a healthy lifestyle is important

Authorized 2012

Reg 432/2012

Folate contributes to normal homocysteine metabolism.

Conditions: Reg 1924/2006 art 10(2) + Annex: claim may only be used for food which is at least a "source of folate"

Authorized 2012

Commission Reg 1135/2014 (Reg 1924/2006 Article 14(1)(a) reduction of disease risk authorization)

Supplemental folic acid intake increases maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects in the developing foetus.

Conditions: Commission Reg 1135/2014 implementing Reg 1924/2006 Article 14(1)(a): target population is women of childbearing age; daily supplemental intake of folic acid 400 µg for at least one month before and up to three months after conception

Authorized 2014

🇧🇷 ANVISA · 1 claim

IN 28/2018 Anexo V alegação funcional

O ácido fólico auxilia na formação das células vermelhas do sangue.

Conditions: IN 28/2018 Anexo V: alegação restrita a suplementos cujo aporte diário do nutriente atenda à quantidade mínima do Anexo II (240 μg para adultos)

Authorized 2018

Common use cases

  • periconceptional supplementation for neural tube defect prevention
  • maternal nutrition in pregnancy
  • megaloblastic anaemia adjunct (with B12 confirmed)
  • homocysteine reduction
Ask Agent Axor